Literature DB >> 14533836

Onycholysis with the appearance of a "sunset" secondary to capecitabine.

Kimberly L Maino1, Christopher Norwood, Mitchell E Stashower.   

Abstract

Capecitabine is an antineoplastic agent that is currently the only effective treatment for patients with advanced or metastatic breast cancer in whom anthracycline or taxoid treatment has failed. Dermatologic side effects have included hand-foot syndrome and one case of onycholysis. We report a case of onycholysis with appearance of a "sunset" induced by capecitabine.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14533836

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


  5 in total

1.  Nail and periungual toxicity following capecitabine therapy.

Authors:  Mario Vaccaro; Olga Barbuzza; Fabrizio Guarneri; Biagio Guarneri
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

2.  Nail Changes Induced by Chemotherapeutic Agents.

Authors:  Neerja Saraswat; Aradhana Sood; Rajesh Verma; Dhramesh Kumar; Sushil Kumar
Journal:  Indian J Dermatol       Date:  2020 May-Jun       Impact factor: 1.494

Review 3.  Nail Changes With Chemotherapeutic Agents and Targeted Therapies.

Authors:  Shankila Mittal; Niti Khunger; Satya Pal Kataria
Journal:  Indian Dermatol Online J       Date:  2022-01-24

4.  Compound mucocutaneous adverse effects of oral capecitabine in a patient.

Authors:  Hyacinth Peter Pinto; Ramesh M Bhat; Dinesh Shet; Sukumar Dandekeri
Journal:  Indian Dermatol Online J       Date:  2014-07

Review 5.  Onychomadesis associated with chemotherapy: case report and mini literature review.

Authors:  Ang Li; Yanqiong Li; Lingzhi Ge; Ping Li; Wenfei Li
Journal:  Drug Des Devel Ther       Date:  2017-08-14       Impact factor: 4.162
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.